DiscoverUpToDate TalkFrequency for dosing of oral iron; Risk of late recurrence after endocrine therapy for breast cancer
Frequency for dosing of oral iron; Risk of late recurrence after endocrine therapy for breast cancer

Frequency for dosing of oral iron; Risk of late recurrence after endocrine therapy for breast cancer

Update: 2018-01-23
Share

Description

In this episode of UpToDate Talk, Dr. Stanley Schrier joins us to discuss an article from Lancet Haematology on a new paradigm for the dosing of oral iron, and Dr. Dan Hayes discusses his meta-analysis from the New England Journal of Medicine on the risk of late recurrence after adjuvant endocrine therapy for breast cancer. Dr. Jennifer Tirnauer hosts.

Figure on hepcidin in UpToDate: https://www.uptodate.com/contents/image?imageKey=HEME%2F105245
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Frequency for dosing of oral iron; Risk of late recurrence after endocrine therapy for breast cancer

Frequency for dosing of oral iron; Risk of late recurrence after endocrine therapy for breast cancer

UpToDate